Enter your email address
Submit
Write your message
Volume 18, Issue 2 (May 2024)
IJT 2024, 18(2): 93-98 |
Back to browse issues page
Ethics code: MUFS/F/PH/1/21
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hassanein O, El-Elaimy I A, Bayomy M F, Shehata A M, Ibrahim H M. Effect of Taurine on Controlling the Side Effects of Valproic Acid in Epileptic Rats. IJT 2024; 18 (2) :93-98
URL: http://ijt.arakmu.ac.ir/article-1-1306-en.html
URL: http://ijt.arakmu.ac.ir/article-1-1306-en.html
Omar Hassanein * 
1, Ibrahim A. El-Elaimy2 , Mohamed F.F. Bayomy3 , Ahmed M. Shehata4 , Hany M. Ibrahim2
1, Ibrahim A. El-Elaimy2 , Mohamed F.F. Bayomy3 , Ahmed M. Shehata4 , Hany M. Ibrahim2
1- Zoology Department, Faculty of Science, Menoufia University, Shebin El-Kom, Meoufia, Egypt , omarhassanein@science.menofia.edu.eg
2- Zoology Department, Faculty of Science, Menoufia University, Shebin El-Kom, Meoufia, Egypt
3- Department of General Biology, Center of Basic Sciences, Misr University for Science and Technology, Giza, Egypt
4- Advanced Research Unit, Egyptian Drug Authority, Cairo, Egypt
2- Zoology Department, Faculty of Science, Menoufia University, Shebin El-Kom, Meoufia, Egypt
3- Department of General Biology, Center of Basic Sciences, Misr University for Science and Technology, Giza, Egypt
4- Advanced Research Unit, Egyptian Drug Authority, Cairo, Egypt
Abstract: (607 Views)
Background: Valproic acid (VPA) is a well-known antiepileptic drug; however, it has adverse effects on different body organs, particularly as a result of inducing oxidative stress in the liver. Taurine (Tau) is an amino acid prevalent in the brain that possesses anti-tumor, anti-toxic, and antioxidant properties. This study aimed to investigate the potential of the co-treatment of Tau in mitigating the deleterious effects of VPA in pentylenetetrazole (PTZ) epileptic rats.
Methods: A total of 42 rats were divided into six groups of seven as follows: control group, PTZ-treated group (single dose, 60 mg/kg intraperitoneally [IP]), VPA-treated group (500 mg/kg IP for 14 days), Tau-treated group (100 mg/kg orally for 28 days), VPA+PTZ group, and Tau+VPA+PTZ group. The liver function, antioxidant status, and lipid profile markers were evaluated spectrophotometrically.
Results: The IP injection of PTZ and VPA elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and gamma-glutamyltransferase levels. These treatments caused negative alterations in protein concentrations, antioxidant status, and lipid profile markers of the rats’ sera. The treatment with Tau+VPA, on the other hand, improved liver function, restored fairly normal total protein and albumin levels, and improved malondialdehyde, glutathione peroxidase, and total antioxidant capacity concentrations. Furthermore, the Tau+VPA treatment significantly controlled total cholesterol, triglycerides, high-density lipoprotein, and low-density lipoprotein levels, compared to the VPA+PTZ treatment.
Conclusion: The treatment with Tau+VPA is highly effective in controlling the unfavorable side effects of VPA in an epileptic rat model.
Methods: A total of 42 rats were divided into six groups of seven as follows: control group, PTZ-treated group (single dose, 60 mg/kg intraperitoneally [IP]), VPA-treated group (500 mg/kg IP for 14 days), Tau-treated group (100 mg/kg orally for 28 days), VPA+PTZ group, and Tau+VPA+PTZ group. The liver function, antioxidant status, and lipid profile markers were evaluated spectrophotometrically.
Results: The IP injection of PTZ and VPA elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and gamma-glutamyltransferase levels. These treatments caused negative alterations in protein concentrations, antioxidant status, and lipid profile markers of the rats’ sera. The treatment with Tau+VPA, on the other hand, improved liver function, restored fairly normal total protein and albumin levels, and improved malondialdehyde, glutathione peroxidase, and total antioxidant capacity concentrations. Furthermore, the Tau+VPA treatment significantly controlled total cholesterol, triglycerides, high-density lipoprotein, and low-density lipoprotein levels, compared to the VPA+PTZ treatment.
Conclusion: The treatment with Tau+VPA is highly effective in controlling the unfavorable side effects of VPA in an epileptic rat model.
References
1. Gaby AR. Natural Approaches to Epilepsy. Altern Med Rev. 2007;12(1):9-24. [Link]
2. Engelborghs S, D'Hooge R, De Deyn PP. Pathophysiology of epilepsy. Acta Neurol Belg. 2000;100(4):201-13. [Link]
3. Jennum P, Sabers A, Christensen J, Ibsen R, Kjellberg J. Socioeconomic outcome of epilepsy surgery: a controlled national study. Seizure. 2016;42:52-56. [doi:10.1016/j.seizure.2016.09.016]
4. Martinc B, Grabnar I, Vovk T. The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.Curr Neuropharmacol.2012;10(4):328-43. [doi:10.2174/157015912804143504] [pmid: 23730257]
5. Sharma V, Nehru B, Munshi A, Jyothy A. Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. Methods Find Exp Clin Pharmacol. 2010;32(4): 227-32. [doi:10.1358/mf.2010.32.4.1452090] [pmid: 20508869]
6. de Kinderen RJA, Evers SM, Rinkens R, Postulart D, Vader CI, Majoie MH, et al. Side-effects of antiepileptic drugs: the economic burden. Seizure. 2104;23(3):184-90. [doi:10.1016/j.seizure.2013.11.009]
7. Ustundag UV, Tunali S, Alev B, Ipekci H, Emekli‐Alturfan E, Akbay TT, et al. Effects of chard (Beta Vulgaris L. Var. Cicla) on cardiac damage in valproic acid-induced toxicity. J Food Biochem. 2016;40(2):132-39. [doi:10.1111/jfbc.12202]
8. Lahneche, A. M. Boucheham R, Boubekri N, Bensaci S, Bicha S, Bentamenne A, et al. Sodium Valproate-Induced Hepatic Dysfunction in Albino Rats and Protective Role of n-Butanol Extract of Centaurea sphaerocephalaL. Phytopathology. 2017;9(10):1335-43. [doi:10.25258/phyto.v9i10.10458]
9. Saleh DAA, Ismail MA, Ibrahim AM. Nonalcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. Pak J Biol Sci. 2012;15(2):68-77. [doi:10.3923/pjbs.2012.68.77] [pmid: 22545359]
10. Abdou SF, El-Wakeel M, El-Saied MH. Protective effect of silymarin and vitamin E in hepatotoxicity induced by valproic acid in albino rats. J Med Sci. 2014;14(6):290-96. [Link]
11. Zulli A. Taurine in cardiovascular disease. CurrOpin Clin NutrMetab Care. 2011;14(1):57-60. [doi:10.1097/MCO.0b013e328340d863]
12. Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci. 2010;17(1):1-14. [doi:10.1186/1423-0127-17-S1-S6]
13. L'Amoreaux WJ, Cuttitta C, Santora A, Blaiz JF, Tachjadi J, El Idrissi A. Taurine regulates insulin release from pancreatic beta cell lines. J Biomed Sci. 2010;17(1):1-8. [doi:10.1186/1423-0127-17-S1-S11]
14. Mates JM, Segura JA, Alonso FJ, Marquez J. Sulphur-containing non enzymatic antioxidants: therapeutic tools against cancer. Front Biosci. 2012;4:722-48. [Link]
15. Ibrahim HM, Abdul Ghaffar FR, El-Elaimy IA, Gouida MS, Abd El latif HM. Antitumor and immune-modulatory efficacy of dual-treatment based on levamisole and/or taurine in Ehrlich ascites carcinoma-bearing mice. Biomed Pharmacother. 2018;106:43-49. [DOI:10.1016/j.biopha.2018.06.113]
16. Abdul Ghaffar FR, Abd El latif HM, Gouida MS, El-Elaimy IA, Ibrahim HM. Evaluation of the antitoxic effect of levamisole or taurine against high dose of cyclophosphamide in tumor-bearing mice.Arch Oncol Cancer Therap. 2019;2:15-29. [DOI:10.22259/2638-5074.0201002]
17. Wu GF, Ren S, Tang RY, Xu C, Zhou JQ, Lin SM, et al. Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats. Sci Rep.2017;7(1):1-14. [doi:10.1038/s41598-017-05051-3]
18. Hassanein OH, Farid OAA, Shehata AM, El Elaimy IA, Bayomy MFF, Ibrahim HM. Taurine as an adjuvant to valproic acid modulates the epileptic seizures and improves the brain aminergic system in PTZ-kindled rats. Curr Top Pept Protein Res.2021;22:91-9. [Link]
19. Megaraj V, Iida T, Jungsuwadee P, Hofmann AF, Vore M. Hepatobiliary disposition of 3 alpha, 6 alpha, 7 alpha, 12 alpha-tetrahydroxy-cholanoyl taurine: a substrate for multiple canalicular transporters. Drug MetabDispos. 2010;38(10):1723-30. [DOI:10.1124/dmd.110.033480]
20. Das J, Vasan V, Sil PC. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol Appl Pharmacol. 2012;258(2):296-308. [doi:10.1016/j.taap.2011.11.009]
21. Yin Y, Wen K, Wu Y, Kang Y, Lou J. Inhibition of sodium current by taurine magnesium coordination compound prevents cesium chloride-induced arrhythmias. Biol Trace Elem Res. 2012;146:192-98. [doi:10.1007/s12011-011-9240-5]
22. Kapucu A, Üzüm G, Kaptan Z, Akgün-Dar K. Effects of erythropoietin pretreatment on single dose pentylentetrazole-induced seizures in rats. Biotechnic & Histochemistry. 2020;95(6):418-27. [doi:10.1080/10520295.2020.1713398]
23. Tong V, Teng XW, Chang TKH, Abbott FS. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci. 2005;86(2):427-35. [doi:10.1093/toxsci/kfi184]
24. Noor NA, Mohammed HS, Khadrawy YA, Ezz HSA, Radwan NM. Evaluation of the neuroprotective effect of taurine and green tea extract against oxidative stress induced by pilocarpine during status epilepticus. J Basic Appl Zool. 2015;72:8-15. [doi:10.1016/j.jobaz.2015.02.001]
25. Ibrahim HM, Mohammed-Geba K, Tawfic AA, El-Magd, MA. Camel milk exosomes modulate cyclophosphamide-induced oxidative stress and immuno-toxicity in rats. Food Funct. 2019;10(11):7523-32. [doi:10.1039/C9FO01914F]
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. [doi:10.1093/clinchem/18.6.499]
27. Bishr NM, Abdel-Rahman AAH, Ashour AM, Ibrahim, HM. Biochemical effects of Toxoplasma gondii and Neosporacaninium infection on diary bovine models in Menoufia Province, Egypt. Adv Anim Vet Sci. 2021;9(3):379-86. [doi:10.17582/journal.aavs/2021.379.386]
28. Rodrigues AD, Scheffel TB, Scola G, Dos Santos MT, Fank B, Dani C, et al. Purple grape juices prevent pentylenetetrazol-induced oxidative damage in the liver and serum of Wistar rats. Nutr Res. 2013;33(2):120-25. [doi:10.1016/j.nutres.2012.12.002]
29. Khedr AA, Serag El-Din MF, Yossef HE. The protective role of pomegranate (Punicagranatum L.) juice against hepatotoxicity induced by pentylenetetrazol in epileptic rats. Life Sci J. 2015;12(12):119-24. [doi:10.7537/marslsj121215.17]
30. Alqarni F, Eweis HS, Ali A, Alrafiah A, Alsieni M, Karim S, et al. The Effect of Coenzyme Q10 on Liver Injury Induced by Valproic Acid and Its Antiepileptic Activity in Rats. Biomedicines. 2022;10(1):168. [doi:10.3390/biomedicines10010168]
31. Niaraki MS, Fatemeh N, Hossein N, Azam M, Saleh A. Protective Effect of Ghrelin on Sodium Valproate-induced Liver Injury in Rat. J stress Physiol Biochem. 2013;9(1):96-105. [Link]
32. Hamza RZ, Ismail HAA, Khaled HE, El-Shenawy NS. Antioxidant effect of L-cysteine on sodium-valproate-induced oxidative stress in rat liver: biochemical and ultrastructural approaches. Toxicol Environ Chem. 2015;97(8):1041-56. [doi:10.1080/02772248.2015.1077961]
33. Raza M, Al-Bekairi AM, Ageel AM, Qureshi, S. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury. Pharmacol Res. 1997;35(2):153-57. [doi:10.1006/phrs.1997.0134]
34. Khan SK, Shakoor KA, Jan MA, Khattak AM, Shah SH. Study of histopathologic changes in the liver of albino rats, induced by toxic doses of valproic acid. Gomal J Med Sci. 2005;3(1):15-8.
35. Erman F, Balkan J, Cevikbas U, Kocak-Toker N, Uysal M. Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. Amino Acids. 2004;27:199-205. [doi:10.1007/s00726-004-0105-5]
36. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett. 2004;151(2):335-43. [doi:10.1016/j.toxlet.2004.03.002]
37. Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D. Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J PhysiolGastrointest Liver Physiol. 2001;280(6):1274-79. [doi:10.1152/ajpgi.2001.280.6.G1274]
38. Shaalan S, El-Wakkad ASE, Saleh H. protective effect of L-carnitine and baker yeast Saccharomyces cerevislae against hepatic toxicity induced by valproateas antiepileptic drug in rats. Int J Pharm Pharm Sci. 2015;7(5):89-95. [Link]
39. Al-Amoudi WM. Protective effects of fennel oil extract against sodium valproate-induced hepatorenal damage in albino rats. Saudi J Biol Sci. 2016;24(4):915-24. [doi:10.1016/j.sjbs.2016.10.021]
40. Hamza AA, EL hodairy F, Elwy HM. Apium graveolens and Rosmarinus officinalis Protect from Liver Toxicity Induced by Sodium Valproate in Rats and Potentiate its Anticonvulsant. IJSBAR. 2016;30:163-80. [Link]
41. Okdah YA, Ibrahim SA. Effect of aqueous saffron extract (Crocus sativus L.) on sodium valporate-induced histological and histochemical alterations in liver of albino rats. Int J Adv Res. 2014;2(7):735-45. [Link]
42. Shen G, Wang S, Dong J, Feng J, Xu J, Xia F, et al. Metabolic Effect of Dietary Taurine Supplementation on Grouper (Epinephelus coioides): A 1H-NMR-Based Metabolomics Study. Molecules. 2019;24(12):2253. [doi:10.3390/molecules24122253]
43. Chaudhary S, Parvez S. An In Vitro Approach to Assess the Neurotoxicity of Valproic Acid-Induced Oxidative Stress in Cerebellum and Cerebral Cortex of Young Rats. Neuroscience. 2012;225:258-268. [doi:10.1016/j.neuroscience.2012.08.060]
44. Azam F, Prasad M, Thangavel N. Targeting oxidative stress component in the therapeutics of epilepsy. Curr Top Med Chem. 2012;12(9):994-1007. [doi:10.2174/156802612800229224]
45. Mas MR, Comert B, Oncu K, Vural SA, Akay C, Tasci I, et al. The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Hepatol Res. 2004;28(4):207-15. [doi:10.1016/j.hepres.2003.11.012]
46. Gürer H, Ozgünes H, Saygin E, Ercal N. Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ ContamToxicol. 2001;41:397-402. [doi:10.1007/s002440010265]
47. Chen YX. Protective action of taurine on ischemia reperfusion liver injury in rats and its mechanisms. Chin Med J Engl. 1993;73(5):276-79. [pmid: 8221245]
48. Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res. 2002;48(1-2):71-5. [doi:10.1016/S0920-1211(01)00322-9]
49. Kifune A, Kuboto F, Shibata N, Akata T, Kikuchi S. Valproic Acid-Induced Hyperammonemia Encephalopathy with Triphasic Waves. Epilepsia. 2000;41(7): 909-12. [doi:10.1111/j.1528-1157.2000.tb00263.x]
50. Vidya M, Subramanian P. Effects of α-Ketoglutarate on Antioxidants and Lipid Peroxidation Products in Rats Treated with Sodium Valproate. J Appl Biomed. 2006;4:141-46. [Link]
51. Balkan J, Kanbağli O, Aykaç-Toker G, Uysal M. Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol Pharm Bull. 2002;25(9):1231-33. [doi:10.1248/bpb.25.1231]
52. SamadpourMasouleh S, Bagheri R, Ashtary-Larky D, Cheraghloo N, Wong A, YousefiBilesvar O, et al. The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes. Nutrients. 2021;13(11):3958. [doi:10.3390/nu13113958]
53. Chen W, Guo JX, Chang P. The effect of taurine on cholesterol metabolism. Mol Nutr Food Res. 2012;56(5):681-90. [doi:10.1002/mnfr.201100799]
54. Murakami S. Role of taurine in the pathogenesis of obesity. Mol Nutr Food Res. 2015;59(7):1353-63. [doi:10.1002/mnfr.201500067]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
The Iranian Journal of Toxicology
Arak University of Medical Sciences in collaboration with the Iranian Society of Toxicology
Website: http://ijt.arakmu.ac.ir
Email: tox.journal@gmail.com
